Immunoglobulin replacement therapy for the management of hypogammaglobulinemia and secondary immunodeficiency following B-cell targeted therapies in patients with autoimmune diseases: A systematic-narrative hybrid review
Mohammed Yousuf Karim, Ramsay L. Fuleihan, Silvia Sánchez-Ramón, Savino Sciascia, Sara Barmettler, Olivia Boyer, David R. Jayne, Marta Kamieniak, Hirokazu Kanegane, Samia J. Khoury, Sorena Kiani-Alikhan, Viviana Moschese, Christian Pagnoux, Martine Pergent, Johan Prevot, David Ritchie, Donald C. Vinh, Chetan B. Mukhtyar Clinical Immunology
· Elsevier
· DOI: 10.1016/j.clim.2026.110788
The publisher did not provide an abstract — full text is available via the link below.
Mohammed Yousuf Karim, Ramsay L. Fuleihan, Silvia Sánchez-Ramón, Savino Sciascia, Sara Barmettler, Olivia Boyer et al. Immunoglobulin replacement therapy for the management of hypogammaglobulinemia and secondary immunodeficiency following B-cell targeted therapies in patients with autoimmune diseases: A systematic-narrative hybrid review. // Clinical Immunology. – DOI: 10.1016/j.clim.2026.110788. – URL: https://www.sciencedirect.com/science/article/pii/S1521661626001269?dgcid=rss_sd_all
Mohammed Yousuf Karim, Ramsay L. Fuleihan, Silvia Sánchez-Ramón, Savino Sciascia, Sara Barmettler, Olivia Boyer, David R. Jayne, Marta Kamieniak, Hirokazu Kanegane, Samia J. Khoury, Sorena Kiani-Alikhan, Viviana Moschese, Christian Pagnoux, Martine Pergent, Johan Prevot, David Ritchie, Donald C. Vinh, & Chetan B. Mukhtyar Immunoglobulin replacement therapy for the management of hypogammaglobulinemia and secondary immunodeficiency following B-cell targeted therapies in patients with autoimmune diseases: A systematic-narrative hybrid review. Clinical Immunology. https://doi.org/10.1016/j.clim.2026.110788
Mohammed Yousuf Karim, et al. “Immunoglobulin replacement therapy for the management of hypogammaglobulinemia and secondary immunodeficiency following B-cell targeted therapies in patients with autoimmune diseases: A systematic-narrative hybrid review.” Clinical Immunology. doi:10.1016/j.clim.2026.110788.
@article{Karim,
title = {Immunoglobulin replacement therapy for the management of hypogammaglobulinemia and secondary immunodeficiency following B-cell targeted therapies in patients with autoimmune diseases: A systematic-narrative hybrid review},
author = {Karim, Mohammed Yousuf and Fuleihan, Ramsay L. and Sánchez-Ramón, Silvia and Sciascia, Savino and Barmettler, Sara and Boyer, Olivia and Jayne, David R. and Kamieniak, Marta and Kanegane, Hirokazu and Khoury, Samia J. and Kiani-Alikhan, Sorena and Moschese, Viviana and Pagnoux, Christian and Pergent, Martine and Prevot, Johan and Ritchie, David and Vinh, Donald C. and Mukhtyar, Chetan B.},
journal = {Clinical Immunology},
doi = {10.1016/j.clim.2026.110788},
url = {https://www.sciencedirect.com/science/article/pii/S1521661626001269?dgcid=rss_sd_all}
}
Mesenchymal stem cells (MSCs) have emerged as promising therapeutic agents in regenerative medicine, with their therapeutic effects increasingly attributed to intercellular communication and microenvironmental regulation rather than...
Background Scleral remodeling with myofibroblast activation and extracellular matrix (ECM) degradation drives myopia, but mechanisms remain unclear. This study explored USP33’s role and its regulatory network. Methods We analyzed GEO...
Background Lung cancer is one of the leading causes of cancer-related mortality worldwide. Understanding the molecular mechanisms underlying lung cancer progression is critical for identifying novel therapeutic targets. This study...